Total Brain: Signs licencing deal with Alto Neuroscience

Total Brain Signs licencing deal with Alto Neuroscience

  • Total Brain (TTB) has entered a perpetual, non-exclusive licencing deal with Alto Neuroscience
  • Under the deal, TotalBrain will hand over its International Study to Predict Optimized Treatment for Depression (iSpot-D) research data to Alto
  • TotalBrain will receive a one-off licence fee of US$500,000 (A$692,266) for handing over its data, with US$100,000 (A$138,453) payable by January 15
  • The licence is subject to conventional commercial termination provisions and will come into effect immediately
  • Shares in TotalBrain are up a healthy 27.3 per cent and are trading at 14 cents
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns.Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration.Highlights: ECB partners with key global standard setters.Agreements aim...

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly.Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...